Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease

Lan V. PhamDepartment of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]

Muychi T. VangDepartment of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Archito T. TamayoDepartment of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Gary LuDepartment of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Pramoda ChallagundlaDepartment of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Jeffrey L. JorgensenDepartment of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Alex A. RolloDepartment of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Zhishuo OuDepartment of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Liang ZhangDepartment of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Michael WangDepartment of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Richard J. FordDepartment of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Your download is now in progress and you may close this window